News - FinNuclear News Database

Filter by tags: Iodine-131 Clear all tag filters

29 news articles found

Of the 220 research reactors in operation today, only seven are on the African continent. In other words, with 17.2% of the world population and the strongest expected growth in the coming years, Africans have access to only 3% of the world's nuclear research reactor capacity. Marguerite Leonardi, senior advisor at NPC Consulting & Engineering, and Professor Vincent Lukanda Mwamba, Commissaire Général of the Commissariat Général à l’Energie Atomique, explain why that is a concern and why the research reactor in Kinshasa should be restarted urgently.

: Source: World Nuclear News

: Date: Tuesday, 13 October 2020; Original article: world-nuclear-news.org/Articles/Viewpoint-Why-research-reactors-are-so-important-f

Rusatom Healthcare, part of state nuclear corporation Rosatom, will build Russia’s first radiopharmaceutical plant to meet global GMP good manufacturing practice standards. The new production facility will be in Obninsk at the site of LYa Karpov Scientific Research Institute of Physics & Chemistry (NIFKhl) and will produce drugs for targeted cancer therapy. The design of pharmaceutical production will be carried out by the Central Design and Technological Institute. Pre-design work is planned to be completed this year, for commissioning in 2024 production in early 2025.

: Source: NEI Magazine

: Date: Friday, 07 August 2020; Original article: neimagazine.com/news/newsrussia-to-open-radiopharmaceutical-plant-in-obninsk-8064702

Belgium’s Institute for Radioelements (IRE) has produced its first commercial molybdenum-99 (Mo-99) low enriched uranium (LEU) batch for the US market.

: Source: NEI Magazine

: Date: Friday, 08 May 2020; Original article: neimagazine.com/news/newsbelgium-produces-mo-99-for-the-usa-using-leu-fuel-7911908

Belgium's Institute of Radioelements (IRE) has produced its first batch of the medical radioisotope molybdenum-99 (Mo-99) using a low-enriched uranium (LEU) target rather than a high-enriched uranium (HEU) one. The use of HEU is seen as a potential nuclear proliferation risk.

: Source: World Nuclear News

: Date: Tuesday, 05 May 2020; Original article: world-nuclear-news.org/Articles/Belgium-starts-producing-Mo-99-using-LEU

The South African government has replaced the entire board of the South Africa Nuclear Energy Corporation (Necsa) following alleged failures in its statutory duties including legislative non-compliance, non-adherence to shareholder instructions, financial mismanagement and a failure to return the country's radioisotope manufacturing facility to full functionality a year after it was shut down due to safety concerns.

: Source: World Nuclear News

: Date: Monday, 10 December 2018; Original article: world-nuclear-news.org/Articles/South-African-government-replaces-Necsa-board

Production can resume at NTP Radioisotopes' Pelindaba facilities after receiving the go-ahead from South Africa's National Nuclear Regulator (NNR).

Iodine-131

: Source: World Nuclear News

: Date: Monday, 19 November 2018; Original article: world-nuclear-news.org/Articles/South-Africa-to-resume-radioisotope-production

Belarus considering building a new research reactor with assistance from Russian state nuclear corporation, Belta news agency reported on 20 July.

: Source: NEI Magazine

: Date: Tuesday, 31 July 2018; Original article: neimagazine.com/news/newsbelarus-considers-new-research-reactor-6271660

Rusatom Healthcare (part of Rosatom) on 26 July signed a non-binding agreement with the South African Nuclear Energy Corporation of (Necsa) to cooperate on non-power applications of nuclear technology, particularly nuclear medicine.

: Source: NEI Magazine

: Date: Monday, 30 July 2018; Original article: neimagazine.com/news/newssouth-africa-signs-nuclear-medicine-deal-with-russia-6271504

Rusatom Healthcare - a subsidiary of Russian state nuclear corporation Rosatom - and the South African Nuclear Energy Corporation (Necsa) have signed an agreement to cooperate on non-power applications of nuclear technology, particularly nuclear medicine. Under the agreement, the partners plan to construct two small-scale reactors as well as a cyclotron in South Africa for the production of medical isotopes.